Correlation Between SAB Biotherapeutics and TNF Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and TNF Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and TNF Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and TNF Pharmaceuticals,, you can compare the effects of market volatilities on SAB Biotherapeutics and TNF Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of TNF Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and TNF Pharmaceuticals,.

Diversification Opportunities for SAB Biotherapeutics and TNF Pharmaceuticals,

-0.43

Correlation Coefficient

SAB Biotherapeutics  TNF Pharmaceuticals,

Very good diversification

The 3 months correlation between SAB and TNF is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and TNF Pharmaceuticals, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TNF Pharmaceuticals, and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with TNF Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TNF Pharmaceuticals, has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and TNF Pharmaceuticals, go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and TNF Pharmaceuticals,

Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 13.84 times more return on investment than TNF Pharmaceuticals,. However, SAB Biotherapeutics is 13.84 times more volatile than TNF Pharmaceuticals,. It trades about 0.12 of its potential returns per unit of risk. TNF Pharmaceuticals, is currently generating about -0.05 per unit of risk. If you would invest  4.95  in SAB Biotherapeutics on September 24, 2024 and sell it today you would earn a total of  2.76  from holding SAB Biotherapeutics or generate 55.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	75.5%
Values	Daily Returns

SAB Biotherapeutics  vs.  TNF Pharmaceuticals,

SAB Biotherapeutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, SAB Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

TNF Pharmaceuticals,

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in TNF Pharmaceuticals, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady technical and fundamental indicators, TNF Pharmaceuticals, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with SAB Biotherapeutics and TNF Pharmaceuticals,

The main advantage of trading using opposite SAB Biotherapeutics and TNF Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, TNF Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TNF Pharmaceuticals, will offset losses from the drop in TNF Pharmaceuticals,'s long position.

The idea behind SAB Biotherapeutics and TNF Pharmaceuticals, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.